Literature DB >> 33179002

Use of electrochemotherapy in a voluminous chest wall recurrence of triple-negative breast cancer: case report.

Margherita Koleva Radica1, Nicolò Fabbri2, Giorgia Santandrea1, Simona Bonazza1, Antonio Stefanelli3, Paolo Carcoforo1.   

Abstract

Breast cancer is the most common cause of chest wall recurrence, skin, and subcutaneous tissue metastases which mainly occur as multiple nodes in the skin and subcutaneous tissue. When it occurs, surgery (re-excision or totalization) is the treatment of choice. Unfortunately, it is not possible in rare cases for example after multiple plastic reconstructions and particular anatomical sites not eligible for resection. Moreover, in some cases where radiation therapy has already been used, and systemic therapy is ineffective or contraindicated, electrochemotherapy could represent a choice of palliation treatment. The principle of electrochemotherapy is based on a physical approach to permeabilize cells in the tissue exposed to electric pulses with increased cellular uptake of hydrophilic chemotherapeutics as bleomycin. We present a case of a 62-year-old woman suffering from chest wall recurrence of triple-negative breast cancer, previously treated with chemotherapy, surgery, and radiotherapy. The persistence of the tumor disease with abundant losses of blood serum material led the patient to a progressive decay of the general physical conditions. For this reason, we performed an electrochemotherapy session with an improvement in pain management and partial necrosis of the tumor tissue and devascularization that reduced bleeding and serum production leading to a better quality of life. 2020 AME Case Reports. All rights reserved.

Entities:  

Keywords:  Electrochemotherapy (ECT); breast cancer recurrence; case report; palliation

Year:  2020        PMID: 33179002      PMCID: PMC7608727          DOI: 10.21037/acr-20-54

Source DB:  PubMed          Journal:  AME Case Rep        ISSN: 2523-1995


  6 in total

Review 1.  Postmastectomy radiation therapy: indications and controversies.

Authors:  Marie Catherine Lee; Reshma Jagsi
Journal:  Surg Clin North Am       Date:  2007-04       Impact factor: 2.741

2.  Electrochemotherapy in Breast Cancer: A Review of References.

Authors:  G Schmidt; I Juhasz-Böss; E-F Solomayer; D Herr
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-06       Impact factor: 2.915

3.  Bleomycin and other antitumor antibiotics of high molecular weight.

Authors:  H Umezawa
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

4.  Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.

Authors:  Hanne M Nielsen; Marie Overgaard; Cai Grau; Anni R Jensen; Jens Overgaard
Journal:  J Clin Oncol       Date:  2006-04-17       Impact factor: 44.544

5.  Chest wall recurrence after mastectomy does not always portend a dismal outcome.

Authors:  Anees Chagpar; Funda Meric-Bernstam; Kelly K Hunt; Merrick I Ross; Massimo Cristofanilli; S Eva Singletary; Thomas A Buchholz; Frederick C Ames; Sylvie Marcy; Gildy V Babiera; Barry W Feig; Gabriel N Hortobagyi; Henry M Kuerer
Journal:  Ann Surg Oncol       Date:  2003-07       Impact factor: 5.344

Review 6.  Electrochemotherapy in Breast Cancer - Discussion of the Method and Literature Review.

Authors:  Mateusz Wichtowski; Dawid Murawa; Katarzyna Kulcenty; Karolina Zaleska
Journal:  Breast Care (Basel)       Date:  2017-12-03       Impact factor: 2.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.